Contribution of clonogenic leukemic cell characteristics to therapy outcome in patients with acute myeloblastic leukemia.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003114:Colony-Forming Units Assay; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000473:pathology*; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage; D014410:Tumor Stem Cell Assay
D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin